A vs ABUS: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Arbutus Biopharma Corp in 2026
A
Agilent Technologies Inc
$119.77
ABUS
Arbutus Biopharma Corp
$4.58
Key Metrics Comparison
| Metric | A | ABUS | Winner |
|---|---|---|---|
| Market Cap | $34.05B | $850.33M | A |
| P/E Ratio | 25.89 | N/A | A |
| EPS (TTM) | $4.65 | $N/A | A |
| Revenue Growth | 0.1% | -0.3% | A |
| Gross Margin | 52.3% | -79.2% | A |
Analyze A
Full quant analysis
Analyze ABUS
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or ABUS a better investment?
Comparing A and ABUS: Agilent Technologies Inc has a market cap of $34.05B while Arbutus Biopharma Corp has $850.33M. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and ABUS?
A (Agilent Technologies Inc) and ABUS (Arbutus Biopharma Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or ABUS?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: A or ABUS?
A has higher revenue growth at 0.1% vs -0.3% for ABUS.
Which company is more profitable: A or ABUS?
Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to -79.2% for ABUS.
Which is the larger company: A or ABUS?
Agilent Technologies Inc (A) is larger with a market cap of $34.05B compared to $850.33M for ABUS.
Should I buy A or ABUS in 2026?
Both A and ABUS have investment merit. A trades at $119.77 while ABUS trades at $4.58. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and ABUS stock?
Key differences: Market Cap ($34.05B vs $850.33M), P/E Ratio (25.9x vs N/A), Revenue Growth (0.1% vs -0.3%), Gross Margin (52.3% vs -79.2%).